Autonomix Medical Formalizes $2.6M Warrant Inducement, Adds 857K New Warrants at $5.75
AMIX sits 22% above its 52-week low of $4.204.
Summary
Autonomix Medical formalized its $2.6M warrant inducement, issuing 857K new warrants at $5.75 in exchange for immediate exercise of existing warrants. The deal includes a 60-day lock-up and a registration commitment, adding dilution potential but providing critical cash.
Key Events · Financing and Capital Events · AMIX
-
Warrant Inducement Raises $2.6M
Holder exercised 428,731 Series C warrants at a reduced $6.00 strike, generating ~$2.6M in gross proceeds before a 7% placement agent fee and expenses.
-
857K New Warrants Issued at $5.75
As consideration, the holder received 428,731 Series D-1 and 428,731 Series D-2 warrants, each exercisable at $5.75 for 5.5 years. The D-1 warrants include a Black Scholes cash redemption right upon a change of control.
-
Registration Overhang
The company must file a resale registration statement for the new warrant shares within 15 days and have it effective within 45 days (75 if SEC review), creating a near-term overhang.
-
60-Day Equity Lock-Up
Autonomix agreed not to issue equity or equity-linked securities for 60 days, with standard carve-outs for employee plans and strategic transactions.
Analysis · AMIX · Industrial Applications And Services
Autonomix Medical filed the 8-K for its warrant inducement deal, locking in $2.6 million in gross proceeds from the exercise of existing Series C warrants at a reduced $6.00 strike. In exchange, the holder receives 857,462 new warrants (Series D-1 and D-2) exercisable at $5.75 — a slight premium to today's $5.13 stock price. The new warrants carry a 5.5-year term and the D-1 series includes a Black Scholes cash redemption right in a change-of-control, adding potential future cost. The company also commits to a 60-day equity issuance lock-up and must register the new warrant shares within 15 days. This follows the reverse split and Nasdaq compliance regained last month; the cash infusion extends runway but the warrant overhang and registration obligation create near-term dilution risk.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 29.9% of the 1944 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMIX was trading at $5.13 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.8M. The 52-week trading range was $4.20 to $55.44. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.